Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Christopher Astle currently holds 6,503 shares of Zymeworks Inc. (ZYME), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher Astle has been a net seller of ZYME stock. They have purchased $0 and sold $83.4K worth of shares.
Christopher Astle's most recent insider trade was on Jan 8, 2024, when they sold 1,431 shares at $11.22 per share.
Christopher Astle serves as Executive at Zymeworks Inc. (ZYME). They have executed 12 insider transactions totaling $83.4K over their tenure at the company.
Christopher Astle holds the position of Executive at Zymeworks Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Christopher Astle has shown a selling trading pattern, with $0 in total purchases and $83.4K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Christopher Astle was on Jan 5, 2024, when they sold $48.6K worth of ZYME shares. This transaction involved 4,563 shares at $10.65 per share.
Christopher Astle currently owns 6,503 shares of Zymeworks Inc. (ZYME), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Christopher Astle's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Christopher Astle has 12 Form 4 filings on record as an insider at Zymeworks Inc..
Set alerts for Christopher Astle and 40,000+ other insiders.